A.P. Geubel

593 total citations
20 papers, 335 citations indexed

About

A.P. Geubel is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, A.P. Geubel has authored 20 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 9 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in A.P. Geubel's work include Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (6 papers) and Liver Diseases and Immunity (4 papers). A.P. Geubel is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (6 papers) and Liver Diseases and Immunity (4 papers). A.P. Geubel collaborates with scholars based in Belgium, United Kingdom and France. A.P. Geubel's co-authors include Yves Horsmans, Christine Sempoux, J.P. Desager, Jean‐Pierre Desager, Isabelle Leclercq, Nathalie M. Delzenne, Chantal Lefebvre, Yves Guiot, R Brenard and Jacques Rahier and has published in prestigious journals such as Journal of Hepatology, Pharmacology & Therapeutics and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A.P. Geubel

20 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.P. Geubel Belgium	11	156	153	75	61	45	20	335
U. Spengler Germany	8	183 1.2×	154 1.0×	65 0.9×	40 0.7×	69 1.5×	10	408
Hernán Andreu Spain	7	175 1.1×	139 0.9×	160 2.1×	41 0.7×	67 1.5×	10	388
G. Occhino Italy	9	154 1.0×	242 1.6×	43 0.6×	27 0.4×	51 1.1×	16	386
Florencia Vargas Mexico	10	317 2.0×	342 2.2×	172 2.3×	57 0.9×	69 1.5×	16	599
Arjun Venkataramani United States	8	172 1.1×	174 1.1×	71 0.9×	31 0.5×	38 0.8×	12	289
Jerold A. Cohen United States	3	169 1.1×	254 1.7×	50 0.7×	59 1.0×	37 0.8×	4	436
H Henning Germany	8	144 0.9×	162 1.1×	92 1.2×	25 0.4×	43 1.0×	44	317
Selim Giray Nak Türkiye	11	174 1.1×	334 2.2×	121 1.6×	25 0.4×	42 0.9×	33	490
Billur Canbakan Türkiye	13	223 1.4×	369 2.4×	45 0.6×	26 0.4×	30 0.7×	32	484
Masahito Ogiku Japan	10	72 0.5×	84 0.5×	43 0.6×	52 0.9×	73 1.6×	19	357

Countries citing papers authored by A.P. Geubel

Since Specialization

Citations

This map shows the geographic impact of A.P. Geubel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.P. Geubel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.P. Geubel more than expected).

Fields of papers citing papers by A.P. Geubel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.P. Geubel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.P. Geubel. The network helps show where A.P. Geubel may publish in the future.

Co-authorship network of co-authors of A.P. Geubel

This figure shows the co-authorship network connecting the top 25 collaborators of A.P. Geubel. A scholar is included among the top collaborators of A.P. Geubel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.P. Geubel. A.P. Geubel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sempoux, Christine, et al.. (2008). Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?. PubMed. 71(1). 36–8. 9 indexed citations

Nollevaux, Marie‐Cécile, Yves Guiot, Yves Horsmans, et al.. (2005). Hypervitaminosis A‐induced liver fibrosis: stellate cell activation and daily dose consumption. Liver International. 26(2). 182–186. 53 indexed citations

Geubel, A.P., et al.. (1999). Acute hepatitis due to poisoning.. PubMed. 61(4). 468–9. 2 indexed citations

Horsmans, Yves, Peter Karayiannis, C. Cornù, et al.. (1999). Severe exacerbation of liver disease during pregnancy in a thalassemic GBV-C/HGV-positive patient and neonatal hepatitis in offspring. Journal of Medical Virology. 57(2). 122–125. 2 indexed citations

Leclercq, Isabelle, Yves Horsmans, Jean‐Pierre Desager, Nathalie M. Delzenne, & A.P. Geubel. (1998). Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation. Journal of Hepatology. 28(3). 410–416. 54 indexed citations

Sempoux, Christine, et al.. (1997). Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver International. 17(6). 311–315. 30 indexed citations

Horsmans, Yves, et al.. (1997). Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. Alimentary Pharmacology & Therapeutics. 11(1). 165–170. 60 indexed citations

Messiaen, T., et al.. (1996). Hepatic angiomyo(myelo)lipoma: difficulties in radiological diagnosis and interest of fine needle aspiration biopsy. Liver International. 16(5). 338–341. 17 indexed citations

Messiaen, T., Chantal Lefebvre, & A.P. Geubel. (1996). Hepatic abscess likely related to Leptotrichia buccalis in an immunocompetent patient. Liver International. 16(5). 342–343. 13 indexed citations

10.

Hoof, Marc van, et al.. (1995). Anti-Hepatitis C Virus Positivity (Hcv) In Belgian Volunteer Blood Donors: Source Of Contamination And Hcv-Testing Among Donors And Related Recipients.. Acta Clinica Belgica. 50(6). 335–342. 1 indexed citations

11.

Brenard, R, Yves Horsmans, & A.P. Geubel. (1995). [Chronic viral hepatitis and interferons: preliminary results in 60 patients with chronic hepatitis C and cellular mechanism of action].. PubMed. 57(3-4). 230–5. 1 indexed citations

12.

Horsmans, Yves, Jan Lerut, Matteo Donataccio, Jean-Bernard Otté, & A.P. Geubel. (1994). Viral infections and liver transplantation.. PubMed. 57(2). 188–93. 3 indexed citations

13.

Horsmans, Yves, R Brenard, & A.P. Geubel. (1994). Short report: interferon‐α decreases ¹⁴C–aminopyrine breath test values in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 8(3). 353–355. 13 indexed citations

14.

Warny, Michel, R Brenard, C. Cornù, Jean‐Paul Tomasi, & A.P. Geubel. (1993). Anti-neutrophil antibodies in chronic hepatitis and the effect of α-interferon therapy. Journal of Hepatology. 17(3). 294–300. 18 indexed citations

15.

Devuyst, Olivier, Chantal Lefebvre, A.P. Geubel, & Emmanuel Coche. (1993). Acute Cholestatic Hepatitis with Rash and Hypereosinophilia Associated with Ranitidine Treatment. Acta Clinica Belgica. 48(2). 109–114. 12 indexed citations

16.

Geubel, A.P., et al.. (1990). Diffuse biliary tract involvement mimicking primary sclerosing cholangitis after bone marrow transplantation. Journal of Hepatology. 10(1). 23–28. 9 indexed citations

17.

Cornù, C., et al.. (1990). Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study. Journal of Hepatology. 11. S126–S128. 4 indexed citations

18.

Geubel, A.P., et al.. (1989). Primary Sclerosing Cholangitis and Idiopathic Pulmonary Fibrosis: A Case Report. Acta Clinica Belgica. 44(1). 24–30. 1 indexed citations

19.

Geubel, A.P., et al.. (1988). Abnormal methylation capacity in human liver cirrhosis.. PubMed. 8(2). 117–22. 23 indexed citations

20.

Geubel, A.P., et al.. (1987). Increased CYT P-450 dependent function in healthy HBsAg carriers. Pharmacology & Therapeutics. 33(1). 193–196. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact